Operating Lease, Payments of Dianthus Therapeutics, Inc. /DE/ from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Payments for the quarter ending 31 Dec 2025 was $0.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Payments for the twelve months ending 31 Dec 2025 was $300,000, a 25% decline year-over-year.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Lease, Payments for 2025 was $300,000, a 25% decline from 2024.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Lease, Payments for 2024 was $400,000, unchanged from 2023.
  • Dianthus Therapeutics, Inc. /DE/ annual Operating Lease, Payments for 2023 was $400,000, a 94% decline from 2022.
Source SEC data
View on sec.gov
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $300,000 $0 +$200,000 01 Oct 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $100,000 $100,000 -$200,000 -67% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $300,000 $100,000 -$100,000 -50% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $400,000 $100,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $400,000 $200,000 01 Oct 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $300,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $200,000 +$200,000 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $100,000 -$16,355,000 -99% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q2 2023 $19,805,000 $0 -$1,622,000 -100% 01 Apr 2023 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $21,427,000 $16,455,000 +$14,860,000 +932% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $6,567,000 $1,676,000 01 Oct 2022 31 Dec 2022 10-K 23 Mar 2023 2022 FY
Q3 2022 $1,674,000 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $1,622,000 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $1,595,000 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1

Dianthus Therapeutics, Inc. /DE/ Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $300,000 -$100,000 -25% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $400,000 $0 0% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $400,000 -$6,167,000 -94% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $6,567,000 01 Jan 2022 31 Dec 2022 10-K 23 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.